ClearPoint Neuro, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2012 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ClearPoint Neuro, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2012 to Q3 2024.
  • ClearPoint Neuro, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 27.6M shares, a 12% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 27.6M +2.96M +12% Oct 31, 2024 10-Q 2024-11-07
Q2 2024 27.6M +2.96M +12% Jul 31, 2024 10-Q 2024-08-07
Q1 2024 27M +2.39M +9.74% Mar 5, 2024 10-K 2024-03-12
Q3 2023 24.6M +66K +0.27% Nov 1, 2023 10-Q 2023-11-09
Q2 2023 24.6M +148K +0.61% Aug 2, 2023 10-Q 2023-08-08
Q1 2023 24.6M +892K +3.77% May 3, 2023 10-Q 2023-05-11
Q3 2022 24.6M +915K +3.87% Nov 3, 2022 10-Q 2022-11-08
Q2 2022 24.5M +2.12M +9.49% Aug 4, 2022 10-Q 2022-08-10
Q1 2022 23.7M +3.02M +14.6% Mar 3, 2022 10-K 2022-03-09
Q3 2021 23.6M +6.77M +40.1% Nov 9, 2021 10-Q 2021-11-10
Q2 2021 22.4M +6.64M +42.2% Aug 10, 2021 10-Q 2021-08-12
Q1 2021 20.7M +5.18M +33.4% Mar 18, 2021 10-K 2021-03-22
Q3 2020 16.9M +1.66M +10.9% Nov 10, 2020 10-Q 2020-11-12
Q2 2020 15.7M +1.73M +12.4% Aug 10, 2020 10-Q 2020-08-13
Q1 2020 15.5M +4.44M +40.2% Mar 16, 2020 10-K 2020-03-27
Q3 2019 15.2M +4.18M +38% Nov 7, 2019 10-Q 2019-11-13
Q2 2019 14M +2.99M +27.2% Aug 8, 2019 10-Q 2019-08-12
Q1 2019 11.1M +78.3K +0.71% Mar 10, 2019 10-K 2019-04-01
Q3 2018 11M +621K +5.97% Nov 12, 2018 10-Q 2018-11-13
Q2 2018 11M +667K +6.45% Aug 14, 2018 10-Q 2018-08-14
Q1 2018 11M +11M May 1, 2018 10-Q 2018-05-15
Q3 2017 10.4M +6.79M +188% Nov 1, 2017 10-Q 2017-11-06
Q2 2017 10.3M +7.94M +331% Aug 11, 2017 10-Q 2017-08-11
Q1 2017 0 -95.9M -100% May 3, 2017 10-Q 2017-05-09
Q3 2016 3.61M -71.4M -95.2% Nov 1, 2016 10-Q 2016-11-09
Q2 2016 2.4M -72.5M -96.8% Aug 1, 2016 10-Q/A 2016-09-21
Q1 2016 95.9M +21M +28.1% Apr 14, 2016 10-Q 2016-05-06
Q3 2015 75M +16M +27.1% Nov 10, 2015 10-Q 2015-11-13
Q2 2015 74.9M +16M +27.1% Aug 1, 2015 10-Q 2015-08-10
Q1 2015 74.8M +19M +33.9% Mar 13, 2015 10-K 2015-03-17
Q3 2014 59M +499K +0.85% Nov 11, 2014 10-Q 2014-11-14
Q2 2014 59M +638K +1.09% Aug 8, 2014 10-Q 2014-08-11
Q1 2014 55.9M -1.43M -2.5% Mar 21, 2014 10-K 2014-03-28
Q3 2013 58.5M +10.5M +21.8% Nov 8, 2013 10-Q 2013-11-13
Q2 2013 58.3M +10.9M +23% Aug 9, 2013 10-Q 2013-08-14
Q1 2013 57.3M +16.9M +41.7% Mar 1, 2013 10-K/A 2013-08-19
Q3 2012 48M Nov 8, 2012 10-Q 2012-11-14
Q2 2012 47.4M Aug 6, 2012 10-Q 2012-08-14
Q1 2012 40.4M May 10, 2012 10-Q/A 2012-06-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.